NORD Launches IAMRARE Mobile App to Empower Patients
The National Organization for Rare Disorders, affectionately known as NORD, has unveiled a remarkable new mobile application aimed at enhancing patient and caregiver engagement within the rare disease community. This innovative app is designed to supplement the IAMRARE Registry Platform, making the process of contributing to vital research studies significantly more accessible.
Enhancing Participation in Rare Disease Research
This new app enables patients and their caregivers to effortlessly connect with crucial health information regarding rare diseases. Available for download on popular platforms, including Apple’s App Store and Google Play, the IAMRARE mobile app provides a dynamic interface tailored to users' needs. The simplification of data sharing is a game-changer for those affected by rare diseases, helping contribute to much-needed research.
A Shift Towards Accessibility
As more than 95% of the 10,000 known rare diseases lack approved treatments, the timely collection of quality data is imperative. NORD's Chief Executive Officer, Pamela K. Gavin, expresses excitement about the app’s potential, highlighting that it makes participation easier and more engaging, which in turn accelerates the pace of research and the development of new therapies.
Streamlined User Experience for Patients
With most patients accessing the IAMRARE platform through mobile devices, the application was thoughtfully designed for quick access and user-friendly navigation. By using the same login credentials as their online account, users will find it straightforward to connect with the studies they are involved in. The app also includes useful reminders to keep participants engaged and ensure timely contribution to ongoing studies.
Collaboration and Community Impact
NORD first established the IAMRARE platform in 2014, in collaboration with healthcare professionals and regulatory bodies like the U.S. Food and Drug Administration (FDA). This initiative paves the way for patient-powered natural history studies that benefit the rare disease community. To date, over 70 studies have been initiated, accumulating rich data from more than 20,000 participants and encompassing 165 rare diseases.
Empowering Patients through Data
The IAMRARE framework emphasizes the importance of patient involvement throughout all phases of research, making them pivotal partners in the process. Patients are not just participants; they play an integral role from the initial design of studies all the way through to the ownership and analysis of the data collected. This approach not only enhances the quality of research but also instigates significant advancements in treatment methodologies.
Building a Future of Hope
The contribution of IAMRARE data has already manifested in over 30 peer-reviewed publications, leading to the approval of a new therapy. NORD continues to champion efforts that empower patients, helping shape the future landscape of rare disease treatments. Without the commitment and passion of patients sharing their experiences, these scientific milestones would not be achievable.
About NORD
NORD, established in 1983, stands as a dedicated nonprofit organization devoted to supporting individuals with rare diseases in their health journeys. With partnerships linking over 350 disease-specific advocacy groups, NORD is at the forefront of progress in research, care, and policy frameworks aimed at advancing the needs of the rare disease community. To discover more about the IAMRARE app and its initiatives, visit the NORD website.
Frequently Asked Questions
What is the IAMRARE mobile app?
The IAMRARE mobile app is a companion application designed to connect patients and caregivers with research studies related to rare diseases.
How can the app help in rare disease research?
It simplifies the process of sharing health information, ensuring higher quality data is collected from participants.
Who developed the IAMRARE mobile app?
The National Organization for Rare Disorders (NORD) developed the app in collaboration with healthcare experts and the FDA.
How can I download the IAMRARE app?
The app is available on both Apple’s App Store and Google Play Store.
Why is patient engagement important in rare disease studies?
Engaged patients provide critical data that can accelerate research, leading to new therapies and advancements in treatment.
